# RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)

> **NCT05930301** · — · UNKNOWN · sponsor: **Peihua Lu** · enrollment: 12 (estimated)

## Conditions studied

- Cervical

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05930301
- **Lead sponsor:** Peihua Lu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05930301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05930301, "RT201(Tumor Antigen-specific Macrophage Tumor Vaccine)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05930301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*